The Food and Drug Administration is expected to approve KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.
Copyright 2024 NPR
The FDA is expected to approve a new type of schizophrenia drug
Corrected: September 26, 2024 at 5:29 PM EDT
The initial version of this online summary incorrectly stated that the Food and Drug Administration had approved KarXT. The broadcast story reported that the agency was expected to approve the drug soon.
